Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-HbN1wx9o
October 12, 2023jessica-sacher
Biotech news Clinical trials Phage therapy

UCSD will soon open as a clinical trial site for Adaptive Phage Therapeutics’ ACTIVE.2 trial, studying the safety and efficacy of APT’s Phage Bank versus placebo in patients with prosthetic joint infections.

Loading ...
No comments yet. Be the first to comment!